Whilst this is an important perspective, three more recent studies included in this analysis waited for confirmation of sepsis by either positive blood or cerebrospinal fluid culture before initiating adjunctive therapy with IgM-enriched immunoglobulin (36, 43, 49), and still saw a significant mortality benefit compared with controls. This evidence concerns the gene CD40LG and Sepsis.